Literature DB >> 2158833

Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s).

C Boulanger1, V B Schini, H Hendrickson, P M Vanhoutte.   

Abstract

1. The effect of chronic exposure of cultured porcine aortic endothelial cells to eicosapentaenoic acid on the release of indomethacin-insensitive relaxing factor(s) was investigated (a) under bioassay conditions using preconstricted canine coronary artery rings without endothelium and (b) by the measurement of guanosine 3':5'-cyclic monophosphate (cyclic GMP) content of endothelial cells. 2. Exposure of endothelial cells for 8-10 days to eicosapentaenoic acid (2.5 x 10(-5) M) did not affect the relaxing activity of the perfusate from unstimulated endothelial cells. 3. The treatment with eicosapentaenoic acid significantly increased the relaxation of the bioassay ring observed upon stimulation of the endothelial cells with adenosine diphosphate (3 x 10(-8) M to 3 x 10(-4) M) and, to a lesser extent with bradykinin (10(-8) to 3 x 10(-8) M), while the relaxing activity evoked by the calcium ionophore A23187 (3 x 10(-7) M) was not affected. Neither acetylcholine (10(-6) M) nor 5-hydroxytryptamine (10(-6) M) stimulated the release of relaxing factor(s) from control or eicosapentaenoic acid-treated endothelial cells. 4. Bradykinin (10(-7) M), adenosine diphosphate (3 x 10(-5) M), the calcium ionophore A23187 (10(-6) M) and nitric oxide (2 x 10(-6) M) stimulated haemoglobin-sensitive increases in cyclic GMP content of porcine endothelial cells which were unaffected by prior chronic exposure to eicosapentaenoic acid. 5. These results suggest that chronic exposure of porcine aortic endothelial cells to eicosapentaenoic acid increases the release of relaxing factor(s) in response to activation of membrane-associated receptors for purines and kinins. The lack of effect of eicosapentaenoic acid treatment on agonist-stimulated production of cyclic GMP suggests that the enhanced relaxation observed under bioassay conditions is not due to an increased production of nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2158833      PMCID: PMC1917522          DOI: 10.1111/j.1476-5381.1990.tb14673.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.

Authors:  S Moncada; J R Vane
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

2.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

Review 4.  Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function.

Authors:  S Moncada; M W Radomski; R M Palmer
Journal:  Biochem Pharmacol       Date:  1988-07-01       Impact factor: 5.858

5.  Dietary cod-liver oil improves endothelium-dependent responses in hypercholesterolemic and atherosclerotic porcine coronary arteries.

Authors:  H Shimokawa; P M Vanhoutte
Journal:  Circulation       Date:  1988-12       Impact factor: 29.690

6.  Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine.

Authors:  S Katsuki; W Arnold; C Mittal; F Murad
Journal:  J Cyclic Nucleotide Res       Date:  1977-02

7.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

8.  Dietary omega 3 polyunsaturated fatty acids augment endothelium-dependent relaxation to bradykinin in coronary microvessels of the pig.

Authors:  H Shimokawa; L L Aarhus; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

9.  Endothelium-dependent hyperpolarization of canine coronary smooth muscle.

Authors:  M Feletou; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells.

Authors:  W Martin; D G White; A H Henderson
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

View more
  7 in total

1.  Effects of hypoxia and metabolic inhibitors on production of prostacyclin and endothelium-derived relaxing factor by pig aortic endothelial cells.

Authors:  J M Richards; I F Gibson; W Martin
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

2.  Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.

Authors:  Mingyi Yao; David D Roberts; Jeff S Isenberg
Journal:  Pharmacol Res       Date:  2010-10-29       Impact factor: 7.658

3.  Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  G E McVeigh; G M Brennan; G D Johnston; B J McDermott; L T McGrath; W R Henry; J W Andrews; J R Hayes
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

4.  Contrasting effects of treatment with omega-3 and omega-6 essential fatty acids on peripheral nerve function and capillarization in streptozotocin-diabetic rats.

Authors:  K C Dines; M A Cotter; N E Cameron
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

5.  Study of mechanisms of glucocorticoid hypertension in rats: endothelial related changes and their amelioration by dietary fish oils.

Authors:  K Yin; Z M Chu; L J Beilin
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

6.  Docosahexaenoic acid potentiates interleukin-1beta induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells.

Authors:  Masahiko Hirafuji; Takuji Machida; Marito Tsunoda; Atsushi Miyamoto; Masaru Minami
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

7.  Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in response to EPA:DHA 6:1.

Authors:  Faraj Zgheel; Mahmoud Alhosin; Sherzad Rashid; Mélanie Burban; Cyril Auger; Valérie B Schini-Kerth
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.